This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Boucher, D. Articles by Fuks, A. Search for Related Content PubMed PubMed Citation Articles by Boucher, D. Articles by Fuks, A.

Studies on the Control of Gene Expression of the Carcinoembryonic Antigen Family in Human Tissue¹

McGill Cancer Centre [D. B., C. P. S., A. F.] and Department of Biochemistry [D. C., C. P. S.], McGill University, Montreal, Quebec H3G 1Y6, Canada

The control of expression of genes of the carcinoembryonic antigen family was investigated in 22 specimens of malignant and nonmalignant human colonic tissues. These surgical specimens included seven colonic adenocarcinomas that were compared with normal adjacent colonic mucosal tissues from the same individual. mRNA preparations from all colonic tissues expressed three bands of 3.5, 3.0, and 2.6 kilobases on Northern blots probed with carcinoembryonic antigen (CEA) complementary DNA probe while normal liver and spleen were negative. The major band of 3.0 kilobases was 6 to 10 times more intense in the colon tumor specimens than in the matched normal mucosa. However, the tumor/normal ratios of immunoreactive CEA in these pairs varied from 2- to greater than 100-fold. Furthermore, there was no direct proportionality between mRNA levels and gene product expression, suggesting that the known variations in CEA expression in human colonic tissues result from both transcriptional and posttranscriptional control mechanisms. Southern blots of DNA from these specimens did not reveal any gene rearrangements or amplifications accompanying expression. Finally, Southern blots of DNA digested with methylation-sensitive endonucleases and probed with a genomic DNA fragment upstream of CEA gene coding regions demonstrated that CEA expression is correlated with a decreased level of methylation in the 5' region of the CEA gene.

¹ This work was supported by grants to A. F. and C. P. S. from the Medical Research Council of Canada and The National Cancer Institute of Canada.

² Recipient of a studentship from the Medical Research Council of Canada.

³ Recipient of a fellowship from the National Cancer Institute of Canada.

⁴ To whom requests for reprints should be addressed, at McGill Cancer Centre, McGill University, 3655 Drummond St., Montreal, Quebec H3G 1Y6, Canada.

Received 8/12/88. Revised 11/14/88. Accepted 11/16/88.

This article has been cited by other articles:

				P. C.R. Emtage, A. S.Y. Lo, E. M. Gomes, D. L. Liu, R. M. Gonzalo-Daganzo, and R. P. Junghans Second-Generation Anti-Carcinoembryonic Antigen Designer T Cells Resist Activation-Induced Cell Death, Proliferate on Tumor Contact, Secrete Cytokines, and Exhibit Superior Antitumor Activity In vivo: A Preclinical Evaluation Clin. Cancer Res., December 15, 2008; 14(24): 8112 - 8122. [Abstract] [Full Text] [PDF]

				S. Kim-Schulze, H. S. Kim, A. Wainstein, D. W. Kim, W. C. Yang, D. Moroziewicz, P. Y. Mong, M. Bereta, B. Taback, Q. Wang, et al. Intrarectal Vaccination with Recombinant Vaccinia Virus Expressing Carcinoembronic Antigen Induces Mucosal and Systemic Immunity and Prevents Progression of Colorectal Cancer J. Immunol., December 1, 2008; 181(11): 8112 - 8119. [Abstract] [Full Text] [PDF]

				K. H. Bramswig, R. Knittelfelder, S. Gruber, E. Untersmayr, A. B. Riemer, K. Szalai, R. Horvat, R. Kammerer, W. Zimmermann, C. C. Zielinski, et al. Immunization with Mimotopes Prevents Growth of Carcinoembryonic Antigen Positive Tumors in BALB/c Mice Clin. Cancer Res., November 1, 2007; 13(21): 6501 - 6508. [Abstract] [Full Text] [PDF]

				T. M. McDevitt, L. W. Gonzales, R. C. Savani, and P. L. Ballard Role of endogenous TGF-beta in glucocorticoid-induced lung type II cell differentiation Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L249 - L257. [Abstract] [Full Text] [PDF]

				C. H.F. Chan, D. Cook, and C. P. Stanners Increased colon tumor susceptibility in azoxymethane treated CEABAC transgenic mice Carcinogenesis, September 1, 2006; 27(9): 1909 - 1916. [Abstract] [Full Text] [PDF]

				M. J. Duffy Carcinoembryonic Antigen as a Marker for Colorectal Cancer: Is It Clinically Useful? Clin. Chem., April 1, 2001; 47(4): 624 - 630. [Abstract] [Full Text] [PDF]

				R. A. Screaton, L. DeMarte, P. Draber, and C. P. Stanners The Specificity for the Differentiation Blocking Activity of Carcinoembryonic Antigen Resides in Its Glycophosphatidyl-Inositol Anchor J. Cell Biol., August 7, 2000; 150(3): 613 - 626. [Abstract] [Full Text] [PDF]

				K. F. Nolan, C.-O. Yun, Y. Akamatsu, J. C. Murphy, S.-O. Leung, E. J. Beecham, and R. P. Junghans Bypassing Immunization: Optimized Design of ""Designer T Cells"" against Carcinoembryonic Antigen (CEA)-expressing Tumors, and Lack of Suppression by Soluble CEA Clin. Cancer Res., December 1, 1999; 5(12): 3928 - 3941. [Abstract] [Full Text] [PDF]

				R. A. Screaton, L. Z. Penn, and C. P. Stanners Carcinoembryonic Antigen, a Human Tumor Marker, Cooperates with Myc and Bcl-2 in Cellular Transformation J. Cell Biol., May 19, 1997; 137(4): 939 - 952. [Abstract] [Full Text] [PDF]

				W. Hauck and C. P. Stanners Transcriptional Regulation of the Carcinoembryonic Antigen Gene J. Biol. Chem., February 24, 1995; 270(8): 3602 - 3610. [Abstract] [Full Text] [PDF]